2005, a pivotal year for Axis-Shield, with strong growth and profitability

wan.......many thanks.

Provided roll out of Afinion is only being held up by productions issues, then I think that suggests demand has been far higher than expected. Personally, I am not convinced about that, as ASD appeared to be ahead of the game in that they were setting up production lines capable of handling much more than expected initial demand. Time will tell.

Regards non-Afinion products, I did not forget about the Axsym agreement. I just do not think it will make sufficient impact on revenue and/or profits to move them into the realms of the current market cap.

As you say, it is a personal choice about when to re-enter. My thoughts are that good news, even CLIA waiver for Afinion, will only result in a short term spike within the range I've stated previously. I therefore expect the sp to stay within 300p - 330p for most of this year to enable the revenue/profits to grow nearer to justifying current market cap. If it drops significantly below 300p I would be a buyer.